{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:01:00Z","timestamp":1784977260409,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04237-4","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:00:42Z","timestamp":1771344042000},"page":"3516-3526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["S100A10 promotes glycolysis and malignant progression of CCA by activating the HK2\/ERK signaling pathway"],"prefix":"10.1007","volume":"28","author":[{"given":"Yajun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6326-0562","authenticated-orcid":false,"given":"Niu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"2","key":"4237_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/liv.13998","volume":"39","author":"V Cardinale","year":"2019","unstructured":"Cardinale V. Classifications and misclassification in cholangiocarcinoma. Liver Int. 2019;39(2):260\u20132.","journal-title":"Liver Int"},{"issue":"1","key":"4237_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, et al. Cholangiocarcinoma. Nat Rev Dis Primers. 2021;7(1):65.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"4237_CR3","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.suc.2024.04.003","volume":"104","author":"JM Harrison","year":"2024","unstructured":"Harrison JM, Visser BC. Cholangiocarcinoma. Surg Clin N Am. 2024;104(6):1281\u201393.","journal-title":"Surg Clin N Am"},{"issue":"Suppl 1","key":"4237_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.14086","volume":"39","author":"A Forner","year":"2019","unstructured":"Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvise M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):98\u2013107.","journal-title":"Liver Int"},{"issue":"2","key":"4237_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, Kelley RK, Klumpen HJ, Malka D, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(2):127\u201340.","journal-title":"Ann Oncol"},{"issue":"8","key":"4237_CR6","doi-asserted-by":"publisher","first-page":"103647","DOI":"10.1016\/j.esmoop.2024.103647","volume":"9","author":"LT Chen","year":"2024","unstructured":"Chen LT, Vogel A, Hsu C, Chen MH, Fang W, Pangarsa EA, et al. Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer. ESMO Open. 2024;9(8):103647.","journal-title":"ESMO Open"},{"issue":"8","key":"4237_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"DY Oh","year":"2022","unstructured":"Oh DY, Ruth HA, Qin S, Chen LT, Okusaka T, Vogel A, et al. Durvalumab plus Gemcitabine and Cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1(8):EVIDoa2200015.","journal-title":"NEJM Evid."},{"issue":"10391","key":"4237_CR8","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer(KEYNOTE-966):a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401(10391):1853\u201365.","journal-title":"Lancet"},{"issue":"3","key":"4237_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11523-024-01060-1","volume":"19","author":"M Rimini","year":"2024","unstructured":"Rimini M, Masi G, Lonardi S, Nichetti F, Pressiani T, Lavacchi D, et al. Durvalumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in biliary tract cancer: a real-world retrospective, Multicenter study. Target Oncol. 2024;19(3):359\u201370.","journal-title":"Target Oncol"},{"issue":"1076","key":"4237_CR10","doi-asserted-by":"publisher","first-page":"20170061","DOI":"10.1259\/bjr.20170061","volume":"90","author":"P Sahai","year":"2017","unstructured":"Sahai P, Kumar S. External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence. Brit J Radiol. 2017;90(1076):20170061.","journal-title":"Brit J Radiol"},{"issue":"9","key":"4237_CR11","first-page":"CD12814","volume":"9","author":"V Luvira","year":"2021","unstructured":"Luvira V, Satitkarnmanee E, Pugkhem A, Kietpeerakool C, Lumbiganon P, Pattanittum P. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma. Cochrane Database Syst Rev. 2021;9(9):CD12814.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"4237_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"1","key":"4237_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang CH, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23(1):203.","journal-title":"Mol Cancer"},{"issue":"5","key":"4237_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703\u20137.","journal-title":"Cell"},{"issue":"2","key":"4237_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","volume":"77","author":"J Yang","year":"2020","unstructured":"Yang J, Ren B, Yang G, Wang H, Chen G, You L, et al. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 2020;77(2):305\u201321.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"4237_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41419-018-0367-6","volume":"9","author":"J Xiang","year":"2018","unstructured":"Xiang J, Hu Q, Qin Y, Ji S, Xu W, Liu W, et al. TCF7L2 positively regulates aerobic glycolysis via the EGLN2\/HIF-1alpha axis and indicates prognosis in pancreatic cancer. Cell Death Dis. 2018;9(3):321.","journal-title":"Cell Death Dis"},{"issue":"10","key":"4237_CR17","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1111\/jcmm.17303","volume":"26","author":"YY Bao","year":"2022","unstructured":"Bao YY, Zhong JT, Shen LF, Dai LB, Zhou SH, Fan J, et al. Effect of Glut-1 and HIF-1alpha double knockout by CRISPR\/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K\/Akt\/mTOR pathway. J Cell Mol Med. 2022;26(10):2881\u201394.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"4237_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1158\/0008-5472.CAN-21-0403","volume":"82","author":"Y Xia","year":"2022","unstructured":"Xia Y, Wang X, Liu Y, Shapiro E, Lepor H, Tang MS, et al. PKM2 is essential for bladder cancer growth and maintenance. Cancer Res. 2022;82(4):571\u201385.","journal-title":"Cancer Res"},{"issue":"9","key":"4237_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203965","volume":"13","author":"I Serganova","year":"2018","unstructured":"Serganova I, Cohen IJ, Vemuri K, Shindo M, Maeda M, Mane M, et al. LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response. PLoS ONE. 2018;13(9):e203965.","journal-title":"PLoS ONE"},{"issue":"10","key":"4237_CR20","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/biom13101450","volume":"13","author":"GC Okura","year":"2023","unstructured":"Okura GC, Bharadwaj AG, Waisman DM. Recent advances in molecular and cellular functions of S100A10. Biomolecules. 2023;13(10):1450.","journal-title":"Biomolecules"},{"issue":"1","key":"4237_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/156652413804486214","volume":"13","author":"R Donato","year":"2013","unstructured":"Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of S100 proteins. Curr Mol Med. 2013;13(1):24\u201357.","journal-title":"Curr Mol Med"},{"issue":"5","key":"4237_CR22","doi-asserted-by":"publisher","first-page":"12298","DOI":"10.1080\/21655979.2022.2071022","volume":"13","author":"F Ling","year":"2022","unstructured":"Ling F, Lu Q. S100 calcium-binding protein A10 contributes to malignant traits in osteosarcoma cells by regulating glycolytic metabolism via the AKT\/mTOR pathway. Bioengineered. 2022;13(5):12298\u2013308.","journal-title":"Bioengineered"},{"issue":"1","key":"4237_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/cancers15010202","volume":"15","author":"H Lin","year":"2022","unstructured":"Lin H, Yang P, Li B, Chang Y, Chen Y, Li Y, et al. S100A10 promotes pancreatic ductal adenocarcinoma cells proliferation, migration and adhesion through JNK\/LAMB3-LAMC2 axis. Cancers. 2022;15(1):202.","journal-title":"Cancers"},{"key":"4237_CR24","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20222523","author":"R Wei","year":"2023","unstructured":"Wei R, Feng OQ, Hui YZ, Huang X, Ping LS. Prognostic value of the S100 calcium-binding protein family members in hepatocellular carcinoma. 2023. Bioscience Rep. https:\/\/doi.org\/10.1042\/bsr20222523."},{"issue":"7","key":"4237_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00018-022-04392-1","volume":"79","author":"A Kirtonia","year":"2022","unstructured":"Kirtonia A, Pandey AK, Ramachandran B, Mishra DP, Dawson DW, Sethi G, et al. Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR\/ERK1\/2\/AKT\/mTOR cascade. Cell Mol Life Sci. 2022;79(7):362.","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"4237_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207405","volume":"13","author":"J Khoontawad","year":"2018","unstructured":"Khoontawad J, Intuyod K, Rucksaken R, Hongsrichan N, Pairojkul C, Pinlaor P, et al. Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer. PLoS ONE. 2018;13(11):e207405.","journal-title":"PLoS ONE"},{"issue":"1","key":"4237_CR27","doi-asserted-by":"publisher","first-page":"100077","DOI":"10.1016\/j.cellin.2023.100077","volume":"2","author":"D Guo","year":"2023","unstructured":"Guo D, Meng Y, Jiang X, Lu Z. Hexokinases in cancer and other pathologies. Cell Insight. 2023;2(1):100077.","journal-title":"Cell Insight"},{"issue":"21","key":"4237_CR28","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.18632\/oncotarget.26801","volume":"10","author":"J Ma","year":"2019","unstructured":"Ma J, Fan Y, Feng T, Chen F, Xu Z, Li S, et al. Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression. Oncotarget. 2019;10(21):2112.","journal-title":"Oncotarget"},{"issue":"4","key":"4237_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/15548627.2017.1381804","volume":"14","author":"L Jiao","year":"2018","unstructured":"Jiao L, Zhang H, Li D, Yang K, Tang J, Li X, et al. Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2(hexokinase 2). Autophagy. 2018;14(4):671\u201384.","journal-title":"Autophagy"},{"issue":"1","key":"4237_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-021-04394-0","volume":"13","author":"H Yu","year":"2021","unstructured":"Yu H, Yang W, Huang J, Miao X, Wang B, Ren X, et al. GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure. Cell Death Dis. 2021;13(1):1.","journal-title":"Cell Death Dis"},{"key":"4237_CR31","doi-asserted-by":"publisher","first-page":"106555","DOI":"10.1016\/j.phrs.2022.106555","volume":"187","author":"F Li","year":"2023","unstructured":"Li F, He C, Yao H, Zhao Y, Ye X, Zhou S, et al. Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor glycolysis through HK2 mRNA-m6A modification. Pharmacol Res. 2023;187:106555.","journal-title":"Pharmacol Res"},{"key":"4237_CR32","doi-asserted-by":"crossref","unstructured":"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, et al.S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos.GUT.2023 2023\/7\/1;72(7):1370\u201384.","DOI":"10.1136\/gutjnl-2022-327998"},{"key":"4237_CR33","doi-asserted-by":"crossref","unstructured":"Cui X, Huang T, Jiang T, Wang H. Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics. CANCER LETT.2025 2025\/4\/1;614:217540.","DOI":"10.1016\/j.canlet.2025.217540"},{"key":"4237_CR34","doi-asserted-by":"crossref","unstructured":"Dudzinski SO, Newman NB, McIntyre J, Engineer R, Sanford NN, Wo JY, et al. Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinoma. LANCET GASTROENTEROL.2025 2025\/4\/1;10(4):387\u201398.","DOI":"10.1016\/S2468-1253(24)00267-X"},{"key":"4237_CR35","doi-asserted-by":"crossref","unstructured":"Rimassa L, Lamarca A, O'Kane GM, Edeline J, McNamara MG, Vogel A, et al. New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe.LANCET REG HEALTH-EU.2025 2025\/3\/1;50:101170.","DOI":"10.1016\/j.lanepe.2024.101170"},{"key":"4237_CR36","doi-asserted-by":"crossref","unstructured":"Yang X, Popescu NC, Zimonjic DB.DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism. CANCER RES.2011 2011\/4\/15;71(8):2916\u201325.","DOI":"10.1158\/0008-5472.CAN-10-2158"},{"key":"4237_CR37","doi-asserted-by":"crossref","unstructured":"Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. Neurogenic effects of fluoxetine are attenuated in p11(S100A10)knockout mice. BIOL PSYCHIAT.2010 2010\/6\/1;67(11):1048\u201356.","DOI":"10.1016\/j.biopsych.2010.01.024"},{"key":"4237_CR38","doi-asserted-by":"crossref","unstructured":"Wang C, Zhang C, Li X, Shen J, Xu Y, Shi H, et al.CPT1A-mediated succinylation of S100A10 increases human gastric cancer invasion. J CELL MOL MED.2019 2019\/1\/1;23(1):293\u2013305.","DOI":"10.1111\/jcmm.13920"},{"key":"4237_CR39","doi-asserted-by":"crossref","unstructured":"Shan X, Miao Y, Fan R, Qian H, Chen P, Liu H, et al.MiR-590\u20135P inhibits growth of HepG2 cells via decrease of S100A10 expression and Inhibition of the Wnt pathway.INT J MOL SCI.2013 2013\/4\/18;14(4):8556\u201369.","DOI":"10.3390\/ijms14048556"},{"key":"4237_CR40","doi-asserted-by":"crossref","unstructured":"Wang L, Yan W, Li X, Liu Z, Tian T, Chen T, et al.S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin. J OVARIAN RES.2019 2019\/11\/18;12(1):113.","DOI":"10.1186\/s13048-019-0592-3"},{"key":"4237_CR41","doi-asserted-by":"crossref","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. SIGNAL TRANSDUCT TAR.2022 2022\/9\/1;7(1):305.","DOI":"10.1038\/s41392-022-01206-5"},{"key":"4237_CR42","doi-asserted-by":"crossref","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? NAT REV CANCER.2004 2004\/11\/1;4(11):891\u20139.","DOI":"10.1038\/nrc1478"},{"key":"4237_CR43","doi-asserted-by":"crossref","unstructured":"Nguyen T, Shin Y, Ruppa A, Krall AS, Pham J, Chen PC, et al.Galectin-1 modulates glycolysis via a GM1-galactose-dependent pathway to promote hyperthermia resistance in hepatocellular carcinoma.HEPATOLOGY.2025 2025\/5\/21.","DOI":"10.1097\/HEP.0000000000001391"},{"key":"4237_CR44","doi-asserted-by":"crossref","unstructured":"Yuan Y, Fan G, Liu Y, Liu L, Zhang T, Liu P, et al. The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis. CELL MOL IMMUNOL.2022 2022\/4\/1;19(4):504\u201315.","DOI":"10.1038\/s41423-021-00806-5"},{"key":"4237_CR45","doi-asserted-by":"crossref","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha. CELL METAB.2022 2022\/9\/6;34(9):1312\u201324.","DOI":"10.1016\/j.cmet.2022.08.002"},{"key":"4237_CR46","doi-asserted-by":"crossref","unstructured":"Wang P, Guo W, Liu S, Li S, Li J, Ding B, et al. Novel Pt@PCN-Cu-induced cuproptosis amplifies alphaPD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulation. J EXP CLIN CANC RES.2025 2025\/5\/17;44(1):149.","DOI":"10.1186\/s13046-025-03409-4"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04237-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04237-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04237-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:29:21Z","timestamp":1784975361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04237-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["4237"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04237-4","relation":{"references":[{"id-type":"doi","id":"10.1042\/bsr20222523","asserted-by":"subject"}]},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest or plagiarism.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a retrospective study. It has received approval from the Ethics Committee of the First Affiliated Hospital of Air Force Medical University (Approval Number: KY20232280-X-1)), and the individual informed consent of the patients has been waived.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}